The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer.
Mallick
U
U
Harmer
C
C
Hackshaw
A
A
D006728:Hormones / Q000008:administration & dosage*; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage*; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D013964:Thyroid Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000628:therapy; D013965:Thyroidectomy; D013972:Thyrotropin / Q000008:administration & dosage*
D006728:Hormones; D007457:Iodine Radioisotopes; D013972:Thyrotropin